Summary & Overview
HCPCS A2006: Novosorb Synpath Dermal Matrix, Per Square Centimeter
HCPCS Level II code A2006 designates the Novosorb synpath dermal matrix, billed per square centimeter as an add-on to a primary procedure. This code matters nationally because dermal matrices are increasingly used in complex wound care and reconstructive procedures, affecting facility and professional billing across hospital outpatient departments and ambulatory surgery centers. Accurate reporting of an add-on product per square centimeter influences claim completeness and aggregation of product utilization data.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The overview addresses payer coverage patterns, billing considerations for add-on per-unit products, and how facilities capture product use at the claim line level.
Readers will learn the clinical context for use of a dermal matrix product, the service settings where A2006 is most often reported, common billing modifiers and claim-line practices (listed separately), and which data elements are typically needed to support coverage and payment. The summary also highlights where input data is not available and directs readers to seek payer-specific policy language for coverage determinations. This national-level brief is focused on coding and billing context rather than clinical guidance.
Billing Code Overview
HCPCS Level II code A2006 describes the Novosorb synpath dermal matrix, billed per square centimeter. This code is an add-on, intended to be reported separately in addition to a primary procedure when a biologic or synthetic dermal matrix product is applied as part of wound or soft-tissue reconstruction.
Service type: Dermal matrix grafting / biologic wound matrix application.
Typical site of service: Operative settings and procedural environments, including hospital outpatient departments and ambulatory surgery centers where soft-tissue reconstruction or complex wound management procedures are performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old with a chronic full-thickness lower extremity wound after failed conservative care and debridement. The wound demonstrates inadequate granulation and exposed subcutaneous tissue; the surgical team elects to apply a NovoSorb Biodegradable Temporizing Matrix (NovoSorb SynPath dermal matrix) as part of a staged reconstructive wound management strategy. The procedure is performed in an operating room or procedure suite under local anesthesia with sedation or general anesthesia depending on wound extent. The clinical workflow includes preoperative wound assessment and debridement, measurement of the defect in square centimeters, preparation and placement of the dermal matrix cut to size, securement to the wound bed, and documentation of square centimeters of product used for billing with A2006 as an add-on billing line to the primary closure, grafting, or wound repair procedure. Postoperative care includes dressing application, instruction for immobilization or offloading, and scheduled follow-up for assessment of integration and planning for potential skin grafting once neodermis forms.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier applicable/unknown | Rarely used; indicates no modifier applies when required by payer systems. |